BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32216312)

  • 1. Rapid Prostate Cancer Noninvasive Biomarker Screening Using Segmented Flow Mass Spectrometry-Based Untargeted Metabolomics.
    Pinto FG; Mahmud I; Harmon TA; Rubio VY; Garrett TJ
    J Proteome Res; 2020 May; 19(5):2080-2091. PubMed ID: 32216312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine.
    Cerrato A; Bedia C; Capriotti AL; Cavaliere C; Gentile V; Maggi M; Montone CM; Piovesana S; Sciarra A; Tauler R; Laganà A
    Anal Chim Acta; 2021 May; 1158():338381. PubMed ID: 33863412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery.
    Zhang T; Watson DG; Wang L; Abbas M; Murdoch L; Bashford L; Ahmad I; Lam NY; Ng AC; Leung HY
    PLoS One; 2013; 8(6):e65880. PubMed ID: 23823321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry-based metabolomics: A case-control study nested in the Northern Sweden Health and Disease Study.
    Östman JR; Pinto RC; Ebbels TMD; Thysell E; Hallmans G; Moazzami AA
    Int J Cancer; 2022 Dec; 151(12):2115-2127. PubMed ID: 35866293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Hair Biomarker Candidates for Alzheimer's Disease Using Three High Resolution Mass Spectrometry-Based Untargeted Metabolomics Strategies.
    Chang CW; Hsu JY; Hsiao PZ; Chen YC; Liao PC
    J Am Soc Mass Spectrom; 2023 Apr; 34(4):550-561. PubMed ID: 36973238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
    Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
    Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A one-year pilot study comparing direct-infusion high resolution mass spectrometry based untargeted metabolomics to targeted diagnostic screening for inherited metabolic diseases.
    Willems AP; van der Ham M; Schiebergen-Bronkhorst BGM; van Aalderen M; de Barse MMJ; De Gruyter FE; van Hoek IN; Pras-Raves ML; de Sain-van der Velden MGM; Prinsen HCMT; Verhoeven-Duif NM; Jans JJM
    Front Mol Biosci; 2023; 10():1283083. PubMed ID: 38028537
    [No Abstract]   [Full Text] [Related]  

  • 10. GC-MS-based metabolomics reveals new biomarkers to assist the differentiation of prostate cancer and benign prostatic hyperplasia.
    Wang W; He Z; Kong Y; Liu Z; Gong L
    Clin Chim Acta; 2021 Aug; 519():10-17. PubMed ID: 33831421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-driven data curation pipeline for LC-MS-based untargeted metabolomics.
    Riquelme G; Bortolotto EE; Dombald M; Monge ME
    Metabolomics; 2023 Mar; 19(3):15. PubMed ID: 36856823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data-Driven Soft Independent Modeling of Class Analogy in Paper Spray Ionization Mass Spectrometry-Based Metabolomics for Rapid Detection of Prostate Cancer.
    Pinto FG; Mahmud I; Rubio VY; Máquina ADV; Furtado Durans AF; Neto WB; Garrett TJ
    Anal Chem; 2022 Feb; 94(4):1925-1931. PubMed ID: 35060703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hydrophilic interaction liquid chromatography-scanning field asymmetric waveform ion mobility spectrometry-time-of-flight mass spectrometry for untargeted metabolomics.
    Szykuła KM; Meurs J; Turner MA; Creaser CS; Reynolds JC
    Anal Bioanal Chem; 2019 Sep; 411(24):6309-6317. PubMed ID: 31011786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary exposure marker discovery for toxicants using ultra-high pressure liquid chromatography coupled with Orbitrap high resolution mass spectrometry and three untargeted metabolomics approaches.
    Hsu JY; Hsu JF; Chen YR; Shih CL; Hsu YS; Chen YJ; Tsai SH; Liao PC
    Anal Chim Acta; 2016 Oct; 939():73-83. PubMed ID: 27639145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untargeted Metabolomic Profile for the Detection of Prostate Carcinoma-Preliminary Results from PARAFAC2 and PLS-DA Models.
    Amante E; Salomone A; Alladio E; Vincenti M; Porpiglia F; Bro R
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31443574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel biomarkers in the early diagnosis of malignant melanoma by untargeted liquid chromatography coupled to high-resolution mass spectrometry-based metabolomics: a pilot study.
    Peña-Martín J; Belén García-Ortega M; Palacios-Ferrer JL; Díaz C; Ángel García M; Boulaiz H; Valdivia J; Jurado JM; Almazan-Fernandez FM; Arias Santiago S; Vicente F; Del Val C; Pérez Del Palacio J; Marchal JA
    Br J Dermatol; 2024 Apr; 190(5):740-750. PubMed ID: 38214572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SANIST: a rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers.
    Albini A; Briga D; Conti M; Bruno A; Farioli D; Canali S; Sogno I; D'Ambrosio G; Consonni P; Noonan DM
    Rapid Commun Mass Spectrom; 2015 Oct; 29(19):1703-10. PubMed ID: 26331920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Metabolomic Approach Applied to a Liquid Chromatography Coupled to High-Resolution Tandem Mass Spectrometry Method (HPLC-ESI-HRMS/MS): Towards the Comprehensive Evaluation of the Chemical Composition of Cannabis Medicinal Extracts.
    Citti C; Battisti UM; Braghiroli D; Ciccarella G; Schmid M; Vandelli MA; Cannazza G
    Phytochem Anal; 2018 Mar; 29(2):144-155. PubMed ID: 28915313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation strategies for untargeted metabolomics.
    Patti GJ
    J Sep Sci; 2011 Dec; 34(24):3460-9. PubMed ID: 21972197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
    Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
    Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.